• No results found

Overview and Analysis of Proposed Changes to Meaningful Use in

N/A
N/A
Protected

Academic year: 2021

Share "Overview and Analysis of Proposed Changes to Meaningful Use in"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

(1)

 

 

Overview  and  Analysis  of  

Proposed  Changes  to  

Meaningful  Use  in  2015-­‐16  

 

A  White  Paper  

Impact  Advisors  LLC   400  E.  Diehl  Road   Suite  190   Naperville  IL  60563  

(2)

Executive Summary

On April 10, 2015 CMS published the highly anticipated proposed rule on changes to meaningful use in 2015 and 2016. This proposed rule comes on the heels of the recently published proposed rule on Stage 3 (which only pertains to requirements in 2017 and 2018).

The proposed rule from April 10th would make many important changes to meaningful use requirements in 2015 and 2016:

Beginning in 2015, the EHR reporting period for all hospitals and EPs would follow the calendar year.

For 2015 only, all hospitals and EPs would be able to attest to 90 consecutive days of meaningful use, instead of an entire year.

A “revised” version of Stage 2 would be required for all hospitals and EPs in 2015 and 2016; though, providers currently scheduled to demonstrate Stage 1 this year would have a number of exclusions and alternate measures available.

Changes to 2015 Reporting Period

Beginning in 2015, the EHR reporting period for all hospitals and EPs would follow the calendar year. (Note that the reporting period for EPs is already based on the calendar year, but for hospitals the reporting period is currently based on the Federal Fiscal Year.)

For 2015, all EPs and hospitals would be able to attest to an EHR reporting period of any consecutive 90 days:

EPs would be able to choose any consecutive 90-day period between January 1, 2015 and December 31, 2015.

Hospitals would be able to choose any consecutive 90-day period between October 1, 2014 and December 31, 2015.

The 90-day reporting period – which many providers have been calling for – would only be for 2015. In 2016, a full, 365-day reporting period would again be required (except for first time MU participants, who would continue to be able to attest to any consecutive 90-day period).

“Revised” Stage 2 Objectives and Measures

(3)

In the “revised” version of Stage 2, many existing Stage 1 and Stage 2 measures – specifically those CMS believes to be redundant, duplicative or “topped out” – would be removed.

Removed HOSPITAL Objectives /

Measures Removed EP Objectives / Measures

Record Demographics

Record Vital Signs

Record Smoking Status

Structured Lab Results

Patient List

Summary of Care - Measure 1 - Measure 3

eMAR

Advanced Directives

Electronic Notes

Imaging Results

Family Health History

Structured Labs to Ambulatory Providers

Record Demographics

Record Vital Signs

Record Smoking Status

Clinical Summaries

Structured Lab Results

Patient List

Patient Reminders

Summary of Care - Measure 1 - Measure 3

Electronic Notes

Imaging Results

Family Health History

Of the existing objectives and measures that CMS would retain in the “revised” version of Stage 2, virtually all would have the exact same scope and threshold that they currently do. There are four important exceptions:

The second measure of the “Patient Electronic Access” objective would only require that “at least 1 patient discharged from the hospital during the EHR reporting period views, downloads or transmits his or her health information to a third party.”

The EP-only “Secure Messaging” measure would only require a yes/no attestation to the statement “the capability for patients to send and receive a secure electronic message was enabled during the EHR reporting period.”

The threshold of the Summary of Care measure requiring a summary of care document to be electronically transmitted at transitions of care would stay at 10%, but the transmission would be able to occur via “any electronic means” rather than only via Direct.

(4)

Attesting to the “Revised” Version of Stage 2

All hospitals and EPs – regardless of current Stage – would be required to attest to the “revised” version of Stage 2 in 2015... but there would be many exclusions and alternate measures available for providers currently scheduled to demonstrate Stage 1 this year. For example, CMS would allow Stage 1 providers to use a lower threshold for certain Stage 2 measures in 2015. Additionally, there would be exclusions available for “revised” Stage 2 measures that do not have a Stage 1 equivalent. [See the table below for details.] The only exclusion available for providers currently scheduled to be on Stage 2 in 2015 would be for hospitals that had not planned to select the (previously optional) e-prescribing measure this year.

“Revised” Stage 2 Objectives and Measures

[Note: measures in red represent proposed changes from current Stage 2 requirements]

PROPOSED OBJECTIVES AND MEASURES FOR ALL HOSPITALS AND EPs IN 2015, 2016 & 2017

For Providers Scheduled to Be on Stage 1 in 2015 ONLY

Objective Measure(s) Alternate Measure

Available?

Alternate Exclusion Available? 1. Medication orders (more than 60%) Yes -- 2. Lab orders (more than 30%) -- Yes

CPOE

3. Radiology orders (more than 30%) -- Yes

e-Rx

Hospital measure:

Electronic prescribing (more than 10% of

discharge medications) [Note: exclusion available for Stage 2 hospitals in 2015] EP measure:

Electronic prescribing (more than 50% of

prescriptions)

Yes --

1. Implement 5 clinical decision support

rules Yes --

CDS

2. Drug-drug and drug-allergy alerts enabled -- -- 1. Online access to information (more than

50% of unique patients) -- --

Patient Electronic Access (V/D/T)

2. View, Download, Transmit (at least one

patient views, downloads, or transmits his or her health information to a third party)

-- Yes

Protect EHI Conduct or review a security risk analysis -- --

Patient Specific Education

Patient-specific education resources identified

by CEHRT are provided to patients (more than 10% of unique patients)

(5)

PROPOSED OBJECTIVES AND MEASURES FOR ALL HOSPITALS AND EPs IN 2015, 2016 & 2017

For Providers Scheduled to Be on Stage 1 in 2015 ONLY

Objective Measure(s) Alternate Measure

Available?

Alternate Exclusion Available?

Med Rec Medication reconciliation performed (more

than 50% of transitions of care) -- Yes Summary of

Care

Create summary of care document using

CEHRT and transmit summary of care document “electronically” (more than 10% of transitions of care; no specific transport standards required)

-- Yes

Secure Messaging [EP only]

EP measure:

During the EHR reporting period, the capability for patients to send and receive a secure

electronic message with the provider was fully

enabled.

-- Yes

Public Health

EPs: 2 of 5 measures must be successfully met* Hospitals: 3 of 6 measures must be successfully met*

1. Immunization Registry Reporting (active engagement with a public health agency) 2. Syndromic Surveillance Reporting (active

engagement with a public health agency) 3. Case Reporting (active engagement with a

public health agency)

4. Public Health Registry Reporting (active engagement with a public health agency)** 5. Clinical Data Registry Reporting (active

engagement to submit data to a clinical data registry)**

6. Electronic Reportable Laboratory Result

Reporting (active engagement with a public

health agency) [Hospital only]

-- --

*In 2015 only: EPs scheduled to be on Stage 1 would only have to successfully meet 1 of 5 public health measures; hospitals scheduled to be on Stage 1 would only have to successfully meet 2 of 6 public health measures.  

**Measures #4 and #5 for Public Health Registry Reporting and Clinical Data Registry Reporting may be counted more than once if more than one Public Health Registry or Clinical Data Registry is available.

It is important to note that the proposed exclusions and alternate measures would only be for 2015 – and, except for the inpatient e-prescribing exclusion, would only apply to providers scheduled to be on Stage 1 this year.

(6)

requirements under the “revised” version of Stage 2 in 2016. The following chart provides details on the proposed timeline.

Key Takeaways

The proposed change to shorten the length of the 2015 reporting period was expected; the “revised” version of Stage 2 was not. The sheer number of changes CMS is proposing in the 200+ page document caught almost everyone by surprise – especially since many of the changes would apply to the current reporting period. Between the various exclusions, alternate measures, and other modifications, there is A LOT of information for providers to digest, and the reality is this proposed rule is nowhere near as straightforward and simple as most were expecting.

Although the proposed rule is complex, most of the changes in theory should make it easier to achieve meaningful use in 2015. However, 2016 could now be unexpectedly challenging, especially for hospitals that had been planning to defer the e-prescribing measure until Stage 3.

(7)

Perhaps the most important item to keep in mind is this is a proposed rule, not an interim final rule. So, there will be a 60-day comment period, and then CMS will publish the final rule (probably in the late summer or fall). Given the changes will apply to the current meaningful use reporting period though, this timetable could very well make planning tricky for providers, since we won’t know for sure which of the proposed changes will actually be finalized until the 2015 reporting period is more than halfway over!

About Impact Advisors

Impact Advisors provides high-value strategy and implementation services to help healthcare clients drive clinical and operational performance excellence through the use of technology. We partner with industry-leading organizations to identify and implement improvements in quality, safety and value. Our Associates are experienced professionals with deep domain expertise and a commitment to delivering results.

For more information visit: www.impact-advisors.com

Follow us on Facebook and LinkedIn

Copyright © 2015 Impact Advisors, LLC. All rights reserved.

These materials are provided to you by Impact Advisors as a professional courtesy for personal use only and may not be sold. Please appropriately credit/cite your source as

“Impact Advisors, LLC.”

References

Related documents

Please note that selecting “Previous Page” prior to saving will result in the data on the current screen not being saved.. 54 Eligible Hospitals Meaningful Use Stage 1 7.9

EP/Hospital CAH that transitions or refers their patient to another setting/provider of care (1) creates a summary of care record using CEHRT and (2) electronically exchanges

Exclusion: Providers may claim an exclusion for measure 2 if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1, which does not have an

As the final component to meaningful use attestation in 2014, Clinical Quality Measures must be submitted electronically (Option 1) or manually entered during the attestation

The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for > 10% of such transitions and referrals

6 Implement 5 clinical  decision support  interventions and  drug/drug and  drug/allergy •1 to 5 clinical  decisions •Combined 2  measures NONE

 EPs and EHs attesting to 2014 Stage 1 objectives and measures or Stage 2 Meaningful Use must upload proof of 2014 CEHRT.  EPs and EHs that plan to take advantage of CMS

• Change to Stage 1 Objective: Inclusion of an alternate measure - more than 30 percent of medication orders created by the EP during the EHR reporting period are recorded using